![]() |
Dyslipidemia |
Free Subscription
1 Clin Cardiol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Dyslipidemia is free of charge.
Lipid-Lowering Effect and Safety of Ezetimibe and Atorvastatin 5 mg in Patients
With Primary Hypercholesterolemia or Mixed Dyslipidemia: A Randomized,
Double-Blind, Parallel, Multicenter, Phase 3 Clinical Trial.
Clin Cardiol. 2025;48:e70138.
PubMed
Abstract available
The role of dietary inflammatory index in metabolic diseases: the associations,
mechanisms, and treatments.
Eur J Clin Nutr. 2024 Oct 21. doi: 10.1038/s41430-024-01525.
PubMed
Abstract available
Target Populations for Novel Triglyceride-Lowering Therapies.
J Am Coll Cardiol. 2025;85:1876-1897.
PubMed
Abstract available
Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally
Controlled Hyperlipidemia: A Phase 2 Study.
J Am Coll Cardiol. 2025;85:1821-1835.
PubMed
Abstract available
Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and
Early Human Studies.
J Am Coll Cardiol. 2025;85:1803-1818.
PubMed
Abstract available
Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size
and Number in Hypertriglyceridemia.
J Am Coll Cardiol. 2025;85:1839-1854.
PubMed
Abstract available
L-Kynurenine activates the AHR-PCSK9 pathway to mediate the lipid metabolic and
ovarian dysfunction in polycystic ovary syndrome.
Metabolism. 2025;168:156238.
PubMed
Abstract available
The association between circadian syndrome and possible sarcopenia in an aging
population: A 4-year follow-up study.
PLoS One. 2025;20:e0323211.
PubMed
Abstract available
Relationship between insulin resistance surrogate markers with diabetes and
dyslipidemia: A Bayesian network analysis of Korean adults.
PLoS One. 2025;20:e0323329.
PubMed
Abstract available
Thank you for your interest in scientific medicine.